We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.08 | 1.99501246883 | 4.01 | 4.31 | 3.9216 | 9608 | 4.20517985 | CS |
4 | -0.11 | -2.61904761905 | 4.2 | 4.6445 | 3.9216 | 24084 | 4.26027597 | CS |
12 | 0.37 | 9.94623655914 | 3.72 | 5.0899 | 3.5601 | 25503 | 4.0853681 | CS |
26 | -0.41 | -9.11111111111 | 4.5 | 5.2 | 2.78 | 18853 | 3.97621684 | CS |
52 | 0.77 | 23.1927710843 | 3.32 | 5.2 | 2.78 | 12123 | 3.97601838 | CS |
156 | -10.11 | -71.1971830986 | 14.2 | 14.8 | 2.40101 | 49376 | 7.59396294 | CS |
260 | -9.91 | -70.7857142857 | 14 | 58.5 | 2.40101 | 832600 | 27.89630836 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions